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Abstract  Job’s  syndrome  or  Hyperimmunoglobulin  E  syndrome  (HIES)  is  a  rare  primary  immu-
nodeﬁciency  characterized  by  recurrent  soft  tissue  infections,  coarse  face,  skeletal  and  vascular
abnormalities,  and  markedly  high  levels  of  Immunoglobulin  E.  Eczema  that  resembles  atopic
dermatitis  but  is  refractory  to  traditional  treatment  and  severe  and  recurrent  bacterial  pneu-
monias often  recognized  during  childhood.  Early  diagnosis  and  treatment  prevent  progressive
pulmonary sequellae  and  increase  survival.  About  200  cases  of  HIES  has  been  reported  world-
wide. The  authors  report  a  new  case  of  HIES  with  one  of  the  worst  pulmonary  sequellae  found
in the  literature  on  this  subject  and  review  this  infrequent  topic.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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Um  novo  caso  de  síndrome  de  Job  na  clínica:  um  desaﬁo  de  diagnóstico
Resumo  A  síndrome  de  Job,  ou  síndrome  de  Hiperimunoglobulina  E  (HIES),  é  uma  rara  imun-
odeﬁciência  primária  caracterizada  por  infecc¸ões  recorrentes  de  tecidos  moles,  anomalias
grosseiras faciais,  esqueléticas  e  vasculares,  e  níveis  visivelmente  elevados  de  Imunoglobu-
lina E.  O  eczema  semelhante  à  dermatite  atópica,  mas  refractário  ao  tratamento  tradicional
e pneumonias  graves  e  recorrentes  são  frequentemente  reconhecidas  durante  a  infância.  Um
diagnóstico  e  tratamento  precoces  impedem  sequelas  pulmonares  progressivas  e  aumentam  a
sobrevivência.  Foram  relatados  cerca  de  200  casos  de  HIES  em  todo  o  mundo.  Relatamos  umImunodeﬁciência
primária novo caso  de  HIES  com  uma  das  sequelas  pulmonares  mais  extensas  encontradas  na  análise
bibliográﬁca  sobre  este  assunto,  conjuntamente  com  uma  revisão  sobre  esta  patologia  pouco
frequente.
© 2013  Sociedade  Portuguesa  d
direitos reservados.
∗ Corresponding author.
E-mail address: alain@hvil.hlg.sld.cu (A. Cruz-Portelles).
0873-2159/$  –  see  front  matter  ©  2013  Sociedade  Portuguesa  de  Pneumolo
http://dx.doi.org/10.1016/j.rppneu.2013.07.007e  Pneumologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
gia.  Published  by  Elsevier  España,  S.L.  All  rights  reserved.
1I
T
e
p
H
e
b
h
a
r
l
C
A
s
w
T
a
t
d
s
o
f
a
d
m
s
c
f
l
r
s
m
p
t
1
e
p
N
a
l
(
o
a
t
z
w
m
w
r
t
s
i
t
D
T
f
v
a
t
k
(
t
A
a
v
a
f
i
r
O
n
L
m
(
F
w08  
ntroduction
he  prevalence  of  primary  immunodeﬁciency  (PI)  is  under-
stimated  worldwide.  In  the  United  States,  the  calculated
revalence  of  diagnosed  PI  is  1  in  1200  people  of  all  ages.1
yperimmunoglobulin  E  syndrome  (HIES)  is  among  the  earli-
st  described  syndromes  of  immunodeﬁciency  characterized
y  recurrent  and  severe  pneumonia,  eczema,  and  markedly
igh  levels  of  immunoglobulin  E  (IgE).  Both  male  and  female
re  affected  and  familial  or  sporadic  cases  have  been
eported  worldwide.  The  authors  present  a  new  case  of  HIES,
ately  diagnosed,  with  severe  pulmonary  sequellae.
ase history
 25-year-old  man  came  to  the  hospital  complaining  of  mild
hortness  of  breath,  cough  with  a  yellowish  expectoration,
eakness  and  profuse  unexplained  sweating  without  fever.
he  ﬁrst  symptoms  had  started  three  month  before.  He  was
 nonsmoker  and  had  no  history  of  environmental  exposure
o  chemicals  or  dust.  His  medical  history  was  positive  for
ermatitis  since  the  ﬁrst  24  h  of  his  life,  recurrent  severe
taphylococcal  pneumonias  with  empyema,  chronic  external
titis,  sinusitis  and  dermatitis.  He  also  showed  pathological
ractures  of  the  seventh  left  rib,  intercostal  herpes-zoster
t  two  years  of  age.  Frequent  episodes  of  severe  infectious
iarrhea  were  also  reported.  His  family  history  was  unre-
arkable.
On  physical  examination,  the  patient’s  body  size  was
maller  than  normal  for  his  age  and  sex.  His  face  was
oarse,  with  prominent  forehead,  broad  nasal  bridge,  and
acial  asymmetry.  Marked  joint  hyperextensibility  and  sco-
iosis  was  found.  Chest  examination  showed  a  respiratory
ate  of  24  breaths/min  with  crackles  in  the  left  base.  His  skin
howed  signs  of  pruritic  chronic  dermatitis  spread  all  over,
ainly  at  his  legs,  arms,  and  axillae.  Onychomycosis  was
resent  at  his  ﬁngernails  with  clubbed  ﬁngers.  The  rest  of
he  vital  signs  and  physical  examination  were  unremarkable.
Laboratory  ﬁndings  included:  Hb:  11.0  g/dL,  WBC  count:
5.0  ×  109/L  with  10%  eosinophils  and  52%  neutrophils,
rythrocyte  sedimentation  rate:  80  mm/h,  alkaline  phos-
hatase:  211  U/L  [reference  range  (RR):  35--150  U/L].
o  other  metabolic  abnormalities  were  observed.  Alfa-1
t
h
p
m
igure  1  Chest  radiograph  on  admission  (A:  posteroanterior  and  B:  l
ith air-ﬂuid  level  (*).A.  Cruz-Portelles,  D.  Estopin˜an-Zun˜iga
ntitrypsin,  serum  IgA  and  IgM  levels  were  within  normal
imits.  IgG:  17.0  g/L  (RR:  6.4--13.5  g/L)  and  IgE:  21,300  U/mL
RR:  10--179  U/ml)  were  high.  A  chest  radiograph  performed
n  admission  showed  multiple  thin-walled  cysts  with
ir-ﬂuid  level  consistent  with  superinfection  (Fig.  1).  The
horax  CT  scan  alterations  are  showed  in  Fig.  2.
Topical  antibiotic  and  steroids  creams,  oral  ketocona-
ole,  and  ceftriaxone  and  azithromycin  were  initially  used
ithout  a  signiﬁcant  improvement.  On  the  ﬁfth  day  of  treat-
ent  a  sputum  culture  with  meticillin  resistant  S.  aureus
as  received  and  vancomicin  was  initiated  with  excellent
esults.  No  other  germs  were  isolated  on  blood  or  spu-
um  cultures.  The  diagnosis  of  sporadic  form  of  HIES  (Job’s
yndrome)  was  made  based  on  clinical  and  laboratory  ﬁnd-
ngs.  Skin  lesions  improved  and  prophylactic  treatment  with
rimethoprim-sulfamethoxazole  was  recommended.
iscussion
here  are  two  forms  of  HIES:  an  autosomal-dominant
orm  caused  by  mutations  in  signal  transducer  and  acti-
ator  of  transcription  (STAT)3  (gene  location  17q21),2
nd  a  recessive  form  frequently  associated  with  dedica-
or  of  cytokinesis  (DOCK)8  mutations  (9p24)  or  tyrosine
inase  (TYK)2  (19p13.2)  mutations.  The  dominant  form
familial  or  sporadic)  is  characterized  by  skeletal,  connec-
ive  tissue,  recurrent  pulmonary  infections  and  eczema.
utosomal-recessive  HIES  is  present  with  recurrent  viral
nd  staphylococcal  skin  infections,  frequent  central  ner-
ous  system  abnormalities  and  vasculitis.  This  form  exhibits
 higher  mortality  and  a  lack  of  tendency  to  pneumatoceles
ormation.3,4 Inheritance  usually  follows  an  autosomal  dom-
nant  pattern  with  variable  penetrance  being  the  autosomal
ecessive  pattern  infrequent.
Pathogenesis  is  complex  and  not  very  well  understood.
riginally,  HIES  was  consider  to  be  due  to  a  defect  in
eutrophil  chemotaxis  but  this  is  not  a  constant  feature.
eucocytes  of  HIES  patients  have  defective  cytokine-
ediated  signal  transduction  through  the  Janus  Kinase
JAK)-STAT  pathways.  STAT3  is  a  major  signal  transduc-
ion  protein  involved  in  diverse  pathways  including  wound
ealing,  angiogenesis,  immune  pathways,  and  cancer.  HIES
atients  have  impaired  differentiation  of  Th17  T  cells  from
utations  in  STAT3.5 Experimental  models  in  which  Th17
ateral  view)  showing  multiple  thin-walled  cyst  (pneumatoceles)
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3Figure  2  Chest  CT  scan  on  admission  showed  multiple  and
superinfection  mainly  at  middle  and  lower  lung  ﬁelds,  mild  con
cells  or  Th17  cell-dependent  cytokines  are  defective  have
shown  that  immunity  to  several  extracellular  bacteria,
including  Staphylococcus  aureus, Klebsiella  pneumoniae  and
Candida  albicans,  is  impaired.6
IgE  synthesis  is  normally  enhanced  by  the  Th2  cytokines
IL-4  and  IL-13,  and  repressed  by  Th1  IFN- and  IL-12.  The
two  responses  act  in  opposition  to  each  other.  Decreased
production  of  IFN- by  T  cells  has  been  demonstrated
in  HIES  patients  and  is  probably  related  with  hyper-IgE.7
Eosinophilia  almost  always  is  present  in  these  patients,  at
least  at  some  point,  but  is  not  correlated  with  the  serum  IgE
level  or  with  the  susceptibility  to  severe  infections;  some
older  patients  whose  IgE  levels  were  consistently  low  still
suffered  recurrent  infections.
A  newborn  rash  is  usually  the  ﬁrst  manifestation  of  STAT3
deﬁciency  characterized  by  a  ﬁne  papular  erythematous
eruption  with  superﬁcial  vesicles  and  pustules.  This  rash
which  may  be  located  to  the  face,  scalp,  or  body  folds  and  is
refractory  to  traditional  topical  treatment.  These  areas  are
typically  spared  in  atopic  dermatitis.  Boils,  cold  abscesses,
and  chronic  onychomycosis  can  be  found.4
Severe  and  recurrent  bacterial  pneumonias  are  often
recognized  during  childhood.  The  diagnosis  is  frequently
delay  due  to  the  lack  of  evident  inﬂammatory  signs
contributing  to  the  advance  of  the  infection  and  pneu-
matoceles  and  bronchiectasis  formation  that  predispose  to
secondary  infections.  Frequent  pathogens  isolated  in  HIES
are  S.  aureus,  Streptococcus  pneumoniae,  H.  inﬂuenzae,
and  Candida  that  typically  respond  promptly  to  appropri-
ate  antimicrobial  therapy.  Secondary  infections  are  often
caused  by  Pseudomonas  aeruginosa, Aspergillus, and  non-
tuberculous  mycobacterias  and  have  been  more  frequently
associated  with  complications  and  mortality  than  primary
infections.8
Characteristic  craniofacial  features  resemble  one
another  HIES  patients  more  than  their  own  family  members.
Facial  characteristics  include  coarse  face,  prominent  fore-
head,  a  broad  nasal  bridge,  prognathism,  facial  asymmetry,
and  retained  primary  teeth.  Skeletal  manifestations  such  as
joint  hyperextensibility,  scoliosis,  osteopenia,  pathologicge  pneumatoceles,  some  with  air-ﬂuid  level  consistent  with
ation,  bronchiectasis,  and  left  pleural  thickening.
ractures,  and  Chiari  1  malformation  have  been  reported.4
ascular  alterations  such  as  dilation,  tortuosity  and
neurysms  of  middle-sized  arteries  producing  myocardial
nd  brain  lacunar  infarction,  as  well  as  arterial  hypertension
ave  been  observed.9 The  incidence  of  malignant  disease
n  HIES  is  higher,  particularly  non-Hodgkin’s  and  Hodgkin’s
ymphoma.
Diagnosis  is  made  based  on:  (1)  clinical  ﬁndings  -
entioned  above-  guided  by  a  scoring  system  originally
eveloped  with  genetic  linkage  studies10:  a  patient  with  a
unctuation  higher  than  14  is  considered  affected,  (2)  lab
ndings  that  include  mild  to  moderate  eosinophilia  in  over
0%  of  patients  and  markedly  high  IgE  (>10  times  normal)
evels,  and  (3)  genetic  tests.  The  latest  should  be  performed
or  conﬁrmation  but  mutations  are  not  always  found  and
enetic  analyses  are  not  available  in  all  medical  centers.
he  most  important  differential  diagnosis  for  HIES  eczema  is
topic  dermatitis.  Other  PI  disorders  like  Omenn  syndrome,
iskott--Aldrich  syndrome,  and  Netherton  syndrome  have  to
e  ruled  out.11
Treatment  of  patient  with  HIES  focuses  on  the  following:
.  Skin  care.  Effective  skin  care  often  depends  on  control
of  skin  infections.  Bleach  baths  and  swimming  in  chlori-
nated  pools  are  highly  effective  in  patients  with  severe
dermatitis.  Topical  corticosteroids  and  antibiotics,  and
hydrating  measures  for  eczema,  is  essential.
.  Antimicrobial  prophylaxis.  S.  aureus  infection  prophy-
laxis  is  often  given.  Cotrimoxazole  (2.5  mg/kg  of  the
trimethoprim  component  twice  daily),  a semisynthetic
penicillin,  or  an  oral  cephalosporin  which  targets  S.
aureus  can  be  used.  Frequency  and  length  of  antibiotic
prophylaxis  depends  on  medical  decision  because  no  con-
trolled  trials  have  been  performed.  The  role  of  antifungal
prophylaxis  is  unknown.
.  Treatment  of  infections.  Systemic  bacterial  or  fungal
infections  are  often  severe  and  a  selection  of  the  correct
antibiotic  drug  is  crucial.  Intensive  treatment,  focus-
ing  on  the  most  probable  pathogen  trying  to  obtain  its
susceptibility,  could  be  lifesaving.  Although  S.  aureus  is
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the  most  frequent  germ  reported  as  a  cause  of  pneu-
monias,  gram-negative  bacteria  (including  Pseudomonas)
and  fungus  has  been  often  recognized  as  a  cause  of
complications  and  death.8
.  Management  of  pulmonary  complications.  Empyema  is
relatively  common  and  requires  drainage.  Pulmonary
large  cysts  may  become  secondarily  infected  and  be  a
source  of  infection,  bleeding,  and  possibly  death.  On  the
other  hand,  thoracic  surgery  can  be  complicated  by  poor
expansion  of  the  remaining  lung  after  surgery.
.  Immunomodulating  agents.  Intravenous  immunoglobulin
has  been  anecdotally  used  in  HIES  patients  with  low
levels  of  antibodies  after  vaccination  with  inconsistent
results.12 Recombinant  interferon- improved  neutrophil
chemotaxis  in  few  patients,  and  vaccination  for  pre-
venting  infections  could  help  HIES.  However,  none  of
these  treatments  are  actually  recommended  in  the  daily
practice  because  no  clinical  trials  have  been  performed
at  the  present  time.11
.  Hematopoietic  stem  cell  transplantation  has  been  used
in  patients  with  HIES  and  B-cell  lymphoma  with  negative
results  and  is  not  actually  indicated.13,14
.  Other  therapies.  Isotretinoin,  cyclosporin  A,  and  plasma-
pheresis  have  been  tested  on  a  few  patients  but  are
not  generally  indicated.4,11 H2 antagonists  like  cimetidine
seem  to  improve  symptoms.
Prognosis  of  HIES  patients  depends  on  early  diagnosis  and
rompt  treatment  of  complications.  Pulmonary  infections,
leeding  and  lymphoma  are  among  the  leading  causes  of
eath.  Several  studies  have  shown  that  many  cases  of  PI
re  diagnosed  late  or  are  never  diagnosed.  Some  cases  may
e  missed  because  the  patient  dies  before  life-threatening
omplications  from  HIES  are  diagnosed.1 Identiﬁcation  of
ost  children/adults  with  PI  relies  on  the  awareness  of  their
hysicians  and  a  high  index  of  suspicion  leading  to  prompt
eferral  to  specialists  trained  in  the  management  of  these
omplex  diseases.
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